AVANOS MEDICAL (NYSE:AVNS) Sets New 12-Month Low - What's Next?

AVANOS MEDICAL, INC. (NYSE:AVNS - Get Free Report) reached a new 52-week low on Monday . The stock traded as low as $11.68 and last traded at $11.77, with a volume of 131178 shares. The stock had previously closed at $12.35.

Analyst Ratings Changes

Separately, Wall Street Zen raised AVANOS MEDICAL from a "hold" rating to a "buy" rating in a report on Wednesday, March 19th.

AVANOS MEDICAL Stock Performance

The firm has a fifty day simple moving average of $12.46 and a 200 day simple moving average of $14.13. The company has a current ratio of 2.57, a quick ratio of 1.56 and a debt-to-equity ratio of 0.12. The stock has a market cap of $544.71 million, a price-to-earnings ratio of -1.41 and a beta of 1.12.

AVANOS MEDICAL (NYSE:AVNS - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.19 by $0.07. AVANOS MEDICAL had a positive return on equity of 6.26% and a negative net margin of 55.80%. The firm had revenue of $167.50 million during the quarter, compared to analysts' expectations of $161.75 million. During the same quarter in the prior year, the firm posted $0.22 EPS. The company's revenue for the quarter was up .8% on a year-over-year basis. As a group, sell-side analysts expect that AVANOS MEDICAL, INC. will post 1.32 earnings per share for the current year.

Institutional Investors Weigh In On AVANOS MEDICAL

Large investors have recently bought and sold shares of the business. Armistice Capital LLC acquired a new stake in AVANOS MEDICAL during the 1st quarter worth $28,660,000. T. Rowe Price Investment Management Inc. raised its stake in AVANOS MEDICAL by 24.8% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 3,757,576 shares of the company's stock worth $53,847,000 after buying an additional 746,264 shares during the period. Clark Estates Inc. NY acquired a new stake in AVANOS MEDICAL during the 1st quarter worth $7,077,000. Millennium Management LLC raised its stake in AVANOS MEDICAL by 508.3% during the 1st quarter. Millennium Management LLC now owns 547,740 shares of the company's stock worth $7,849,000 after buying an additional 457,703 shares during the period. Finally, Pacer Advisors Inc. acquired a new stake in AVANOS MEDICAL during the 1st quarter worth $6,056,000. 95.17% of the stock is currently owned by institutional investors.

AVANOS MEDICAL Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.